Document is current
Any future updates will be listed below
-
Authors
Lewis, Richard
Habringer, Stefan
Kircher, Malte
Hefter, Maike
Peuker, Caroline Anna
Werner, Rudolf
Ademaj-Kospiri, Valëza
Gäble, Alexander
Weber, Wolfgang
Wester, Hans-Jürgen
Buck, Andreas
Herhaus, Peter
Lapa, Constantin
Keller, Ulrich http://orcid.org/0000-0002-8485-1958
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB824, project C3, SFB824, project Z1, SFB1335, project P3)
Stiftung Charité
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 7 June 2021
Accepted: 7 August 2021
First Online: 21 August 2021
Declarations
:
: Approval of the responsible ethics committees of University Hospital Würzburg and Klinikum rechts der Isar, was obtained for retrospective analysis of imaging and clinical data. All procedures were in accordance of the 1964 Declaration of Helsinki and its later amendments.
: All patients who participated in this study were informed prior to imaging about the intent of data publication. Written consent to participate in the imaging studies was obtained from all participants and can be made available to the editors on request.
: U.K. has served on the advisory board of PentixaPharm, the company that is developing clinical applications for Pentixafor and Pentixather. H.-J.W. is a founder, shareholder and advisory board member of Scintomics GmbH, Fürstenfeldbruck, Germany.
